John Kinsella
Concepts (573)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitric Oxide | 84 | 2023 | 827 | 7.860 |
Why?
| Hernias, Diaphragmatic, Congenital | 25 | 2023 | 187 | 6.500 |
Why?
| Persistent Fetal Circulation Syndrome | 36 | 2022 | 132 | 4.530 |
Why?
| Respiratory Insufficiency | 28 | 2023 | 290 | 3.590 |
Why?
| Extracorporeal Membrane Oxygenation | 29 | 2023 | 240 | 3.430 |
Why?
| Hypertension, Pulmonary | 44 | 2023 | 1736 | 3.320 |
Why?
| Bronchopulmonary Dysplasia | 16 | 2023 | 330 | 2.480 |
Why?
| Administration, Inhalation | 68 | 2023 | 641 | 2.360 |
Why?
| Infant, Newborn | 102 | 2023 | 5040 | 2.290 |
Why?
| Infant, Premature | 30 | 2023 | 477 | 1.890 |
Why?
| High-Frequency Ventilation | 19 | 2006 | 41 | 1.820 |
Why?
| Bronchodilator Agents | 11 | 2020 | 243 | 1.780 |
Why?
| Vasodilator Agents | 15 | 2022 | 307 | 1.750 |
Why?
| Respiratory Distress Syndrome, Newborn | 13 | 2011 | 102 | 1.730 |
Why?
| Hemodynamics | 37 | 2022 | 1017 | 1.700 |
Why?
| Oxygen Inhalation Therapy | 9 | 2015 | 129 | 1.640 |
Why?
| Hernia, Diaphragmatic | 9 | 2021 | 66 | 1.460 |
Why?
| Pulmonary Circulation | 29 | 2006 | 407 | 1.400 |
Why?
| Infant, Premature, Diseases | 6 | 2019 | 89 | 1.340 |
Why?
| Ventricular Dysfunction, Left | 4 | 2022 | 361 | 1.270 |
Why?
| Respiration, Artificial | 25 | 2019 | 526 | 1.210 |
Why?
| Hypoxia | 18 | 2021 | 959 | 1.130 |
Why?
| Vascular Resistance | 27 | 2021 | 337 | 0.960 |
Why?
| Echocardiography | 13 | 2023 | 557 | 0.940 |
Why?
| Humans | 152 | 2023 | 115049 | 0.850 |
Why?
| Oxygen | 19 | 2021 | 854 | 0.850 |
Why?
| Transportation of Patients | 3 | 2020 | 52 | 0.840 |
Why?
| Blood Gas Analysis | 6 | 2021 | 74 | 0.820 |
Why?
| Lung | 30 | 2023 | 3595 | 0.780 |
Why?
| Bronchoconstriction | 1 | 2020 | 27 | 0.720 |
Why?
| Gestational Age | 21 | 2019 | 758 | 0.710 |
Why?
| Ventricular Dysfunction | 1 | 2019 | 16 | 0.690 |
Why?
| Sheep | 38 | 2007 | 764 | 0.680 |
Why?
| Pulmonary Gas Exchange | 11 | 2009 | 117 | 0.680 |
Why?
| Heart Atria | 1 | 2020 | 111 | 0.660 |
Why?
| Fetus | 20 | 2018 | 702 | 0.650 |
Why?
| Cardiovascular System | 1 | 2020 | 126 | 0.640 |
Why?
| Infant | 33 | 2023 | 7946 | 0.640 |
Why?
| Vasodilation | 18 | 2005 | 417 | 0.640 |
Why?
| Ductus Arteriosus, Patent | 4 | 2015 | 50 | 0.630 |
Why?
| Pre-Eclampsia | 1 | 2020 | 165 | 0.620 |
Why?
| Anaphylaxis | 1 | 2020 | 148 | 0.600 |
Why?
| Heart Ventricles | 3 | 2020 | 714 | 0.580 |
Why?
| Trachea | 2 | 2018 | 234 | 0.580 |
Why?
| Critical Care | 5 | 2013 | 476 | 0.560 |
Why?
| Early Medical Intervention | 2 | 2014 | 51 | 0.560 |
Why?
| Pulmonary Surfactants | 6 | 2021 | 101 | 0.550 |
Why?
| Animals, Newborn | 17 | 2007 | 778 | 0.540 |
Why?
| Intensive Care Units | 4 | 2018 | 620 | 0.530 |
Why?
| Prenatal Diagnosis | 1 | 2018 | 169 | 0.530 |
Why?
| Monitoring, Physiologic | 3 | 2019 | 249 | 0.530 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2015 | 18 | 0.520 |
Why?
| Hyaline Membrane Disease | 6 | 1998 | 20 | 0.520 |
Why?
| Blood Coagulation | 1 | 2017 | 221 | 0.520 |
Why?
| Pulmonary Artery | 19 | 2021 | 1028 | 0.510 |
Why?
| Umbilical Arteries | 1 | 2015 | 41 | 0.500 |
Why?
| Severity of Illness Index | 12 | 2020 | 2551 | 0.500 |
Why?
| Radial Artery | 1 | 2015 | 66 | 0.500 |
Why?
| Female | 65 | 2022 | 59617 | 0.460 |
Why?
| Practice Guidelines as Topic | 3 | 2020 | 1398 | 0.450 |
Why?
| Superoxide Dismutase | 2 | 2006 | 305 | 0.450 |
Why?
| Vitamin A | 1 | 2013 | 52 | 0.450 |
Why?
| Oxygen Consumption | 3 | 2015 | 588 | 0.450 |
Why?
| Vitamins | 1 | 2013 | 151 | 0.420 |
Why?
| Male | 51 | 2020 | 55735 | 0.410 |
Why?
| Retrospective Studies | 23 | 2023 | 12548 | 0.400 |
Why?
| Intestinal Obstruction | 1 | 2012 | 40 | 0.390 |
Why?
| Alcohol-Related Disorders | 1 | 2013 | 113 | 0.390 |
Why?
| Phosphodiesterase Inhibitors | 5 | 2013 | 82 | 0.390 |
Why?
| Muscle, Smooth, Vascular | 8 | 2005 | 417 | 0.380 |
Why?
| Hospital Mortality | 3 | 2018 | 777 | 0.370 |
Why?
| Lung Diseases | 6 | 2010 | 703 | 0.360 |
Why?
| Paresis | 1 | 2010 | 28 | 0.350 |
Why?
| Dietary Supplements | 1 | 2013 | 458 | 0.350 |
Why?
| Sulfones | 4 | 2013 | 97 | 0.340 |
Why?
| Emergency Medicine | 1 | 2013 | 220 | 0.340 |
Why?
| Adrenal Insufficiency | 1 | 2010 | 26 | 0.340 |
Why?
| Conscious Sedation | 1 | 2010 | 79 | 0.330 |
Why?
| Survival Rate | 13 | 2022 | 1646 | 0.330 |
Why?
| Intensive Care Units, Neonatal | 1 | 2011 | 177 | 0.330 |
Why?
| Treatment Outcome | 23 | 2017 | 9123 | 0.320 |
Why?
| Herniorrhaphy | 2 | 2020 | 49 | 0.320 |
Why?
| Dipyridamole | 6 | 1998 | 26 | 0.320 |
Why?
| Heart Defects, Congenital | 7 | 2022 | 665 | 0.320 |
Why?
| Muscle Fibers, Skeletal | 1 | 2010 | 185 | 0.310 |
Why?
| Pacemaker, Artificial | 1 | 2009 | 107 | 0.310 |
Why?
| Nose | 2 | 2008 | 55 | 0.310 |
Why?
| Nitric Oxide Synthase | 13 | 2005 | 209 | 0.310 |
Why?
| Anesthetics, Intravenous | 1 | 2008 | 27 | 0.300 |
Why?
| Meconium Aspiration Syndrome | 3 | 2003 | 11 | 0.300 |
Why?
| Fluorocarbons | 2 | 1999 | 94 | 0.290 |
Why?
| Propofol | 1 | 2008 | 43 | 0.290 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3118 | 0.290 |
Why?
| Action Potentials | 1 | 2010 | 406 | 0.280 |
Why?
| Foreign Bodies | 1 | 2008 | 99 | 0.280 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2007 | 123 | 0.280 |
Why?
| Child | 20 | 2022 | 18407 | 0.270 |
Why?
| Cardiac Output | 7 | 2009 | 143 | 0.270 |
Why?
| Animals | 54 | 2022 | 31868 | 0.260 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 928 | 0.260 |
Why?
| Piperazines | 3 | 2013 | 313 | 0.250 |
Why?
| Respiration Disorders | 1 | 2005 | 68 | 0.240 |
Why?
| Respiration | 3 | 2019 | 182 | 0.240 |
Why?
| Preoperative Care | 3 | 2017 | 318 | 0.230 |
Why?
| Ventricular Function, Left | 6 | 2020 | 469 | 0.230 |
Why?
| Heart | 3 | 2019 | 610 | 0.220 |
Why?
| Pregnancy | 15 | 2020 | 5520 | 0.220 |
Why?
| Dose-Response Relationship, Drug | 6 | 2020 | 1857 | 0.220 |
Why?
| Pulmonary Alveoli | 3 | 2021 | 374 | 0.220 |
Why?
| Fatal Outcome | 4 | 2012 | 285 | 0.210 |
Why?
| Nitrites | 1 | 2002 | 74 | 0.210 |
Why?
| Prospective Studies | 10 | 2023 | 6232 | 0.210 |
Why?
| Ductus Arteriosus | 10 | 2005 | 67 | 0.210 |
Why?
| Infant, Very Low Birth Weight | 2 | 2017 | 66 | 0.200 |
Why?
| Antioxidants | 1 | 2006 | 530 | 0.200 |
Why?
| Incidence | 5 | 2015 | 2318 | 0.200 |
Why?
| Respiratory Therapy | 3 | 2003 | 19 | 0.200 |
Why?
| Gastroesophageal Reflux | 2 | 2022 | 233 | 0.200 |
Why?
| Precision Medicine | 2 | 2023 | 340 | 0.190 |
Why?
| Vasoconstriction | 3 | 2005 | 186 | 0.190 |
Why?
| Neuromuscular Nondepolarizing Agents | 1 | 2020 | 8 | 0.180 |
Why?
| Emergency Treatment | 1 | 2002 | 113 | 0.180 |
Why?
| Plethysmography | 1 | 2001 | 104 | 0.180 |
Why?
| Fundoplication | 1 | 2020 | 51 | 0.180 |
Why?
| Randomized Controlled Trials as Topic | 6 | 2019 | 1215 | 0.180 |
Why?
| Patient Care Team | 2 | 2016 | 515 | 0.180 |
Why?
| Papio | 6 | 1995 | 96 | 0.170 |
Why?
| Fluid Therapy | 2 | 2011 | 122 | 0.170 |
Why?
| Carbon Monoxide | 1 | 2000 | 65 | 0.170 |
Why?
| Therapy, Computer-Assisted | 1 | 2020 | 59 | 0.170 |
Why?
| Blood Pressure | 12 | 2014 | 1539 | 0.170 |
Why?
| Critical Illness | 3 | 2014 | 645 | 0.170 |
Why?
| Neoplasm Staging | 3 | 2018 | 1169 | 0.170 |
Why?
| Pulmonary Veins | 2 | 1999 | 85 | 0.170 |
Why?
| Thrombelastography | 1 | 2020 | 179 | 0.160 |
Why?
| Time Factors | 11 | 2017 | 6141 | 0.160 |
Why?
| Risk Factors | 9 | 2020 | 8642 | 0.160 |
Why?
| Treatment Failure | 5 | 2007 | 332 | 0.150 |
Why?
| Continuous Positive Airway Pressure | 1 | 2018 | 51 | 0.150 |
Why?
| Risk | 3 | 2021 | 815 | 0.150 |
Why?
| Blood Coagulation Disorders | 1 | 2020 | 195 | 0.150 |
Why?
| Cerebral Hemorrhage | 2 | 2014 | 96 | 0.150 |
Why?
| Combined Modality Therapy | 6 | 2017 | 1127 | 0.150 |
Why?
| Single-Blind Method | 2 | 2013 | 258 | 0.150 |
Why?
| Retinopathy of Prematurity | 1 | 2019 | 111 | 0.150 |
Why?
| Intubation, Intratracheal | 2 | 2018 | 216 | 0.150 |
Why?
| Pneumonectomy | 1 | 2019 | 125 | 0.150 |
Why?
| Down Syndrome | 1 | 2022 | 335 | 0.150 |
Why?
| Abnormalities, Multiple | 1 | 2019 | 177 | 0.150 |
Why?
| Biological Products | 1 | 2000 | 171 | 0.150 |
Why?
| Emergency Service, Hospital | 1 | 2008 | 1812 | 0.140 |
Why?
| Follow-Up Studies | 10 | 2019 | 4420 | 0.140 |
Why?
| Dyspnea | 1 | 2018 | 218 | 0.140 |
Why?
| Child, Preschool | 13 | 2017 | 9093 | 0.140 |
Why?
| Smoke Inhalation Injury | 3 | 1991 | 19 | 0.140 |
Why?
| Methemoglobin | 2 | 1993 | 19 | 0.140 |
Why?
| Blood Circulation | 3 | 1998 | 34 | 0.140 |
Why?
| Capillary Permeability | 1 | 1997 | 135 | 0.140 |
Why?
| Pulmonary Edema | 1 | 1997 | 116 | 0.140 |
Why?
| Anesthesia, Local | 1 | 2016 | 15 | 0.140 |
Why?
| Glycocalyx | 1 | 2016 | 18 | 0.140 |
Why?
| Mentors | 1 | 2018 | 158 | 0.140 |
Why?
| Survivors | 1 | 2019 | 410 | 0.140 |
Why?
| Heart Rate | 3 | 2009 | 705 | 0.140 |
Why?
| Guidelines as Topic | 1 | 2018 | 245 | 0.140 |
Why?
| Echocardiography, Doppler | 2 | 2001 | 92 | 0.140 |
Why?
| Infant, Newborn, Diseases | 2 | 2014 | 104 | 0.130 |
Why?
| Disease Management | 2 | 2017 | 563 | 0.130 |
Why?
| Cardiac Catheterization | 6 | 2022 | 535 | 0.130 |
Why?
| Ventricular Dysfunction, Right | 1 | 2019 | 218 | 0.130 |
Why?
| Receptors, Platelet-Derived Growth Factor | 1 | 1996 | 13 | 0.130 |
Why?
| Surgical Procedures, Operative | 1 | 2018 | 207 | 0.130 |
Why?
| Prognosis | 6 | 2023 | 3335 | 0.130 |
Why?
| Dimensional Measurement Accuracy | 1 | 2015 | 12 | 0.130 |
Why?
| Faculty, Medical | 1 | 2018 | 232 | 0.130 |
Why?
| Chronic Disease | 8 | 2013 | 1591 | 0.130 |
Why?
| Length of Stay | 4 | 2017 | 951 | 0.130 |
Why?
| Respiratory Function Tests | 4 | 2019 | 523 | 0.130 |
Why?
| Academic Medical Centers | 1 | 2018 | 412 | 0.130 |
Why?
| Thyroid Carcinoma, Anaplastic | 1 | 2016 | 34 | 0.130 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 676 | 0.130 |
Why?
| Neutrophils | 3 | 1999 | 1164 | 0.130 |
Why?
| Risk Assessment | 4 | 2017 | 2976 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2017 | 267 | 0.120 |
Why?
| Cerebrovascular Circulation | 3 | 1995 | 225 | 0.120 |
Why?
| Radiography | 2 | 2008 | 827 | 0.120 |
Why?
| United Kingdom | 2 | 2013 | 227 | 0.120 |
Why?
| Biomarkers | 4 | 2016 | 3419 | 0.120 |
Why?
| Sildenafil Citrate | 4 | 2021 | 57 | 0.120 |
Why?
| Mothers | 1 | 2020 | 652 | 0.120 |
Why?
| Statistics as Topic | 1 | 2015 | 298 | 0.120 |
Why?
| Registries | 5 | 2022 | 1763 | 0.120 |
Why?
| Nitroarginine | 9 | 2005 | 48 | 0.120 |
Why?
| Thrombosis | 1 | 2017 | 301 | 0.120 |
Why?
| Ventilator Weaning | 2 | 2005 | 34 | 0.120 |
Why?
| Vascular Endothelial Growth Factor A | 4 | 2011 | 499 | 0.120 |
Why?
| Pediatrics | 2 | 2019 | 981 | 0.110 |
Why?
| Vasopressins | 1 | 2014 | 56 | 0.110 |
Why?
| Continuity of Patient Care | 1 | 2016 | 253 | 0.110 |
Why?
| Clinical Trials as Topic | 3 | 2008 | 937 | 0.110 |
Why?
| Vasoconstrictor Agents | 1 | 2014 | 112 | 0.110 |
Why?
| Elective Surgical Procedures | 2 | 2011 | 152 | 0.110 |
Why?
| Alcohol Withdrawal Delirium | 1 | 2013 | 8 | 0.110 |
Why?
| Anticoagulants | 1 | 2017 | 546 | 0.110 |
Why?
| Hemorrhage | 1 | 2017 | 618 | 0.110 |
Why?
| Middle Aged | 12 | 2019 | 26830 | 0.110 |
Why?
| Cell Nucleus | 1 | 1996 | 556 | 0.110 |
Why?
| Hypotension | 1 | 2014 | 114 | 0.110 |
Why?
| Renal Dialysis | 1 | 2016 | 369 | 0.110 |
Why?
| Epoprostenol | 3 | 2021 | 133 | 0.100 |
Why?
| Critical Care Nursing | 1 | 2013 | 29 | 0.100 |
Why?
| Diaphragm | 2 | 2023 | 32 | 0.100 |
Why?
| Coronary Circulation | 2 | 1995 | 135 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 235 | 0.100 |
Why?
| Estradiol | 3 | 2000 | 455 | 0.100 |
Why?
| Vascular Diseases | 1 | 2015 | 231 | 0.100 |
Why?
| Aged | 10 | 2019 | 19122 | 0.100 |
Why?
| Early Diagnosis | 1 | 2013 | 218 | 0.100 |
Why?
| Case-Control Studies | 2 | 2018 | 3015 | 0.100 |
Why?
| Catheterization, Swan-Ganz | 1 | 2011 | 8 | 0.100 |
Why?
| Postoperative Complications | 5 | 2017 | 2150 | 0.100 |
Why?
| Delivery Rooms | 1 | 2011 | 6 | 0.100 |
Why?
| Ventilators, Mechanical | 2 | 2016 | 52 | 0.100 |
Why?
| Troponin | 1 | 2011 | 44 | 0.100 |
Why?
| Patient Admission | 1 | 2013 | 175 | 0.100 |
Why?
| Acetylcholine | 5 | 2001 | 179 | 0.090 |
Why?
| Double-Blind Method | 2 | 2009 | 1665 | 0.090 |
Why?
| Disease Models, Animal | 7 | 2007 | 3545 | 0.090 |
Why?
| Respiratory Mechanics | 3 | 1999 | 57 | 0.090 |
Why?
| Diseases in Twins | 1 | 2012 | 175 | 0.090 |
Why?
| Death, Sudden, Cardiac | 1 | 2012 | 160 | 0.090 |
Why?
| Cardiac Output, Low | 1 | 1991 | 64 | 0.090 |
Why?
| DNA-Binding Proteins | 2 | 2007 | 1318 | 0.090 |
Why?
| Communication | 1 | 2016 | 744 | 0.090 |
Why?
| Delivery, Obstetric | 1 | 1991 | 118 | 0.090 |
Why?
| Monitoring, Intraoperative | 2 | 2008 | 39 | 0.090 |
Why?
| Infusions, Intravenous | 2 | 2009 | 372 | 0.090 |
Why?
| Vitamin D Deficiency | 1 | 2012 | 158 | 0.090 |
Why?
| Transforming Growth Factor beta1 | 1 | 2011 | 154 | 0.090 |
Why?
| Physicians | 1 | 2018 | 772 | 0.090 |
Why?
| Endothelium, Vascular | 5 | 2016 | 850 | 0.090 |
Why?
| Platelet-Derived Growth Factor | 2 | 2003 | 82 | 0.080 |
Why?
| Hospitalization | 1 | 2018 | 1755 | 0.080 |
Why?
| Abdomen | 1 | 2010 | 104 | 0.080 |
Why?
| Thoracic Surgical Procedures | 1 | 2010 | 56 | 0.080 |
Why?
| Positive-Pressure Respiration | 2 | 2000 | 68 | 0.080 |
Why?
| Vitamin D | 1 | 2012 | 340 | 0.080 |
Why?
| Endothelin Receptor Antagonists | 3 | 1998 | 58 | 0.080 |
Why?
| Endothelins | 3 | 2000 | 61 | 0.080 |
Why?
| Airway Obstruction | 1 | 1991 | 168 | 0.080 |
Why?
| Logistic Models | 3 | 2020 | 1839 | 0.080 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2011 | 220 | 0.080 |
Why?
| Patient Readmission | 1 | 2013 | 606 | 0.080 |
Why?
| Point-of-Care Systems | 1 | 2010 | 139 | 0.080 |
Why?
| Nitric Oxide Synthase Type III | 6 | 2007 | 184 | 0.080 |
Why?
| Regional Blood Flow | 4 | 1998 | 428 | 0.080 |
Why?
| Neoplasms | 2 | 2019 | 2106 | 0.080 |
Why?
| Anesthetics, Combined | 1 | 2008 | 5 | 0.080 |
Why?
| Transcription Factors | 1 | 1996 | 1531 | 0.080 |
Why?
| Hydrocortisone | 1 | 2010 | 267 | 0.080 |
Why?
| Chest Wall Oscillation | 1 | 2007 | 4 | 0.070 |
Why?
| Adrenal Cortex Hormones | 1 | 2011 | 499 | 0.070 |
Why?
| Acute Disease | 2 | 2005 | 915 | 0.070 |
Why?
| Lung Neoplasms | 2 | 2019 | 2201 | 0.070 |
Why?
| Receptors, Endothelin | 3 | 2000 | 49 | 0.070 |
Why?
| Sex Distribution | 1 | 2008 | 335 | 0.070 |
Why?
| 3',5'-Cyclic-GMP Phosphodiesterases | 2 | 1998 | 17 | 0.070 |
Why?
| Survival Analysis | 2 | 2009 | 1211 | 0.070 |
Why?
| Analysis of Variance | 5 | 2014 | 1229 | 0.070 |
Why?
| Microspheres | 3 | 1991 | 123 | 0.070 |
Why?
| Leukomalacia, Periventricular | 1 | 2006 | 7 | 0.070 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 2 | 2004 | 103 | 0.070 |
Why?
| Purines | 3 | 2013 | 159 | 0.070 |
Why?
| Neoplasm Recurrence, Local | 2 | 2010 | 856 | 0.070 |
Why?
| Piperidines | 1 | 2008 | 162 | 0.070 |
Why?
| Pilot Projects | 4 | 2016 | 1375 | 0.070 |
Why?
| Cross-Over Studies | 2 | 1998 | 441 | 0.070 |
Why?
| Swine | 2 | 2003 | 704 | 0.070 |
Why?
| Electroencephalography | 1 | 2008 | 362 | 0.070 |
Why?
| Endothelin-1 | 5 | 2000 | 167 | 0.070 |
Why?
| Signal Transduction | 3 | 2005 | 4525 | 0.060 |
Why?
| Intracranial Hemorrhages | 1 | 2006 | 76 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2006 | 2389 | 0.060 |
Why?
| Enzyme Inhibitors | 7 | 2005 | 752 | 0.060 |
Why?
| Adult | 9 | 2014 | 30658 | 0.060 |
Why?
| Atrial Natriuretic Factor | 2 | 1996 | 57 | 0.060 |
Why?
| Lung Compliance | 1 | 2005 | 49 | 0.060 |
Why?
| Airway Resistance | 1 | 2005 | 33 | 0.060 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 249 | 0.060 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2005 | 40 | 0.060 |
Why?
| Predictive Value of Tests | 1 | 2010 | 1812 | 0.060 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 225 | 0.060 |
Why?
| Pulmonary Wedge Pressure | 2 | 2022 | 63 | 0.060 |
Why?
| Practice Patterns, Physicians' | 1 | 2013 | 1178 | 0.060 |
Why?
| Amides | 1 | 2005 | 88 | 0.060 |
Why?
| Carbon Dioxide | 4 | 1999 | 218 | 0.060 |
Why?
| Carcinoma | 2 | 2016 | 199 | 0.060 |
Why?
| Colorectal Neoplasms | 1 | 2010 | 617 | 0.060 |
Why?
| Coronary Artery Bypass | 1 | 2005 | 196 | 0.060 |
Why?
| Home Nursing | 1 | 2003 | 26 | 0.060 |
Why?
| Cost-Benefit Analysis | 3 | 2011 | 544 | 0.060 |
Why?
| Birth Weight | 1 | 2006 | 440 | 0.050 |
Why?
| Bronchoalveolar Lavage | 1 | 2003 | 84 | 0.050 |
Why?
| Cohort Studies | 3 | 2022 | 4904 | 0.050 |
Why?
| Cyclic GMP | 3 | 1999 | 78 | 0.050 |
Why?
| Esophagus | 1 | 2005 | 226 | 0.050 |
Why?
| Endothelial Growth Factors | 1 | 2002 | 50 | 0.050 |
Why?
| Cross-Sectional Studies | 1 | 2013 | 4411 | 0.050 |
Why?
| Lymphokines | 1 | 2002 | 111 | 0.050 |
Why?
| Thyroid Neoplasms | 2 | 2016 | 263 | 0.050 |
Why?
| Forced Expiratory Volume | 2 | 2016 | 476 | 0.050 |
Why?
| Embryonic and Fetal Development | 3 | 2000 | 94 | 0.050 |
Why?
| Surgical Flaps | 1 | 2023 | 121 | 0.050 |
Why?
| Intermittent Positive-Pressure Ventilation | 2 | 1993 | 9 | 0.050 |
Why?
| Mouth Mucosa | 1 | 2022 | 79 | 0.050 |
Why?
| Phenotype | 2 | 2023 | 2815 | 0.050 |
Why?
| Mosaicism | 1 | 2022 | 60 | 0.050 |
Why?
| Sequence Deletion | 1 | 2022 | 168 | 0.050 |
Why?
| Recombinant Proteins | 1 | 2005 | 1237 | 0.050 |
Why?
| Evaluation Studies as Topic | 2 | 1992 | 169 | 0.050 |
Why?
| Forkhead Transcription Factors | 1 | 2022 | 171 | 0.050 |
Why?
| Uterus | 1 | 2002 | 192 | 0.050 |
Why?
| Surveys and Questionnaires | 1 | 2013 | 4631 | 0.050 |
Why?
| Milrinone | 1 | 2021 | 24 | 0.050 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 349 | 0.050 |
Why?
| Labor, Obstetric | 1 | 2001 | 52 | 0.050 |
Why?
| Ligation | 5 | 2002 | 76 | 0.050 |
Why?
| Calibration | 1 | 2001 | 126 | 0.040 |
Why?
| Injections, Intra-Arterial | 1 | 2000 | 25 | 0.040 |
Why?
| Protoporphyrins | 1 | 2000 | 17 | 0.040 |
Why?
| Inflammation | 1 | 2010 | 2485 | 0.040 |
Why?
| Patient Transfer | 1 | 2002 | 144 | 0.040 |
Why?
| Hydrocarbons, Brominated | 1 | 1999 | 5 | 0.040 |
Why?
| Observational Studies as Topic | 1 | 2019 | 90 | 0.040 |
Why?
| Postoperative Period | 2 | 2016 | 292 | 0.040 |
Why?
| Potassium Channel Blockers | 1 | 1999 | 29 | 0.040 |
Why?
| Rats | 4 | 2005 | 4973 | 0.040 |
Why?
| Angiography | 1 | 1999 | 177 | 0.040 |
Why?
| Constriction, Pathologic | 1 | 1999 | 210 | 0.040 |
Why?
| Scotland | 1 | 2018 | 12 | 0.040 |
Why?
| Drug Synergism | 2 | 1998 | 317 | 0.040 |
Why?
| Leukocyte Count | 2 | 1997 | 292 | 0.040 |
Why?
| Asphyxia Neonatorum | 1 | 1998 | 15 | 0.040 |
Why?
| Disease Progression | 2 | 2017 | 2389 | 0.040 |
Why?
| Blood Vessels | 1 | 2000 | 180 | 0.040 |
Why?
| Body Weight | 2 | 2005 | 873 | 0.040 |
Why?
| Immunohistochemistry | 4 | 2005 | 1634 | 0.040 |
Why?
| Frontal Bone | 1 | 1997 | 13 | 0.040 |
Why?
| Receptor, Endothelin A | 4 | 2000 | 59 | 0.040 |
Why?
| Occipital Bone | 1 | 1997 | 18 | 0.040 |
Why?
| Cephalometry | 1 | 1997 | 28 | 0.040 |
Why?
| Growth | 1 | 1997 | 56 | 0.040 |
Why?
| Arterial Pressure | 1 | 2017 | 99 | 0.040 |
Why?
| Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| Ventricular Function, Right | 1 | 2019 | 252 | 0.030 |
Why?
| Syndecan-1 | 1 | 2016 | 27 | 0.030 |
Why?
| Heparan Sulfate Proteoglycans | 1 | 2016 | 22 | 0.030 |
Why?
| Gastrostomy | 1 | 1997 | 89 | 0.030 |
Why?
| Patient Selection | 1 | 2000 | 646 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 1997 | 165 | 0.030 |
Why?
| Arginine | 2 | 1994 | 238 | 0.030 |
Why?
| Expectorants | 1 | 2016 | 24 | 0.030 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2016 | 15 | 0.030 |
Why?
| Body Height | 1 | 1997 | 180 | 0.030 |
Why?
| Endothelin-3 | 1 | 1996 | 3 | 0.030 |
Why?
| Clinical Protocols | 1 | 2017 | 234 | 0.030 |
Why?
| Interrupted Time Series Analysis | 1 | 2016 | 44 | 0.030 |
Why?
| Arteriovenous Fistula | 1 | 2016 | 29 | 0.030 |
Why?
| Vascular Patency | 1 | 2016 | 97 | 0.030 |
Why?
| Ireland | 1 | 2016 | 24 | 0.030 |
Why?
| Interferon-Stimulated Gene Factor 3 | 1 | 1996 | 1 | 0.030 |
Why?
| Lung Injury | 2 | 2011 | 198 | 0.030 |
Why?
| Stroke Volume | 1 | 2019 | 510 | 0.030 |
Why?
| Algorithms | 2 | 2000 | 1489 | 0.030 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 1996 | 35 | 0.030 |
Why?
| Thyroidectomy | 1 | 2016 | 52 | 0.030 |
Why?
| Enteral Nutrition | 1 | 1997 | 157 | 0.030 |
Why?
| Substance Withdrawal Syndrome | 1 | 1998 | 159 | 0.030 |
Why?
| Luciferases | 1 | 1996 | 142 | 0.030 |
Why?
| Steroids | 1 | 2016 | 147 | 0.030 |
Why?
| Age Factors | 2 | 2000 | 2894 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 1999 | 1355 | 0.030 |
Why?
| Genetic Counseling | 1 | 2015 | 66 | 0.030 |
Why?
| Prostaglandins | 1 | 1995 | 78 | 0.030 |
Why?
| Genes, Reporter | 1 | 1996 | 257 | 0.030 |
Why?
| Blotting, Northern | 3 | 2000 | 193 | 0.030 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2015 | 49 | 0.030 |
Why?
| Indiana | 1 | 2015 | 27 | 0.030 |
Why?
| Tyrosine | 1 | 1996 | 216 | 0.030 |
Why?
| Tracheostomy | 1 | 2016 | 100 | 0.030 |
Why?
| Nitric Oxide Synthase Type II | 3 | 2001 | 157 | 0.030 |
Why?
| Psychomotor Performance | 1 | 1997 | 280 | 0.030 |
Why?
| Peptides, Cyclic | 4 | 1998 | 254 | 0.030 |
Why?
| Aorta | 4 | 1998 | 389 | 0.030 |
Why?
| Primary Prevention | 1 | 2016 | 171 | 0.030 |
Why?
| Young Adult | 1 | 2009 | 10498 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2015 | 125 | 0.030 |
Why?
| Drug Administration Schedule | 2 | 2011 | 719 | 0.030 |
Why?
| Endothelium | 1 | 1995 | 112 | 0.030 |
Why?
| Organ Dysfunction Scores | 1 | 2014 | 39 | 0.030 |
Why?
| Base Sequence | 2 | 1996 | 2119 | 0.030 |
Why?
| Vasomotor System | 3 | 2002 | 39 | 0.030 |
Why?
| Infant, Low Birth Weight | 1 | 2015 | 125 | 0.030 |
Why?
| Costs and Cost Analysis | 2 | 2009 | 196 | 0.030 |
Why?
| Transcriptional Activation | 1 | 1996 | 337 | 0.030 |
Why?
| Life Support Care | 1 | 2014 | 28 | 0.030 |
Why?
| United States | 3 | 2012 | 12227 | 0.030 |
Why?
| Schools, Medical | 1 | 2015 | 122 | 0.030 |
Why?
| Hypertension | 1 | 2002 | 1058 | 0.030 |
Why?
| Blood Flow Velocity | 2 | 1992 | 390 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 275 | 0.030 |
Why?
| Prevalence | 1 | 2019 | 2255 | 0.030 |
Why?
| Drug Evaluation | 1 | 1993 | 77 | 0.030 |
Why?
| Lung Transplantation | 1 | 2015 | 246 | 0.030 |
Why?
| Antihypertensive Agents | 1 | 1997 | 430 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1996 | 2796 | 0.030 |
Why?
| Reference Values | 3 | 2002 | 748 | 0.030 |
Why?
| Decision Making | 1 | 2019 | 782 | 0.030 |
Why?
| Child Development | 1 | 1997 | 389 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 1996 | 616 | 0.030 |
Why?
| Acute Lung Injury | 1 | 2016 | 300 | 0.030 |
Why?
| Diagnostic Imaging | 1 | 2015 | 290 | 0.030 |
Why?
| Aged, 80 and over | 2 | 2016 | 6357 | 0.030 |
Why?
| Liver | 1 | 2020 | 1681 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 447 | 0.030 |
Why?
| Brain | 2 | 1997 | 2380 | 0.030 |
Why?
| Lactic Acid | 1 | 2014 | 278 | 0.030 |
Why?
| Streptococcus agalactiae | 1 | 1993 | 81 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2012 | 63 | 0.030 |
Why?
| Asthma | 1 | 2005 | 2051 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 1995 | 296 | 0.030 |
Why?
| Brain Chemistry | 1 | 1992 | 116 | 0.030 |
Why?
| United States Food and Drug Administration | 1 | 2012 | 172 | 0.020 |
Why?
| Isotonic Solutions | 1 | 2011 | 38 | 0.020 |
Why?
| Streptococcal Infections | 1 | 1993 | 127 | 0.020 |
Why?
| Odds Ratio | 1 | 2014 | 957 | 0.020 |
Why?
| Fetal Diseases | 2 | 2003 | 148 | 0.020 |
Why?
| Phosphorylation | 1 | 1996 | 1572 | 0.020 |
Why?
| Intensive Care Units, Pediatric | 1 | 1993 | 147 | 0.020 |
Why?
| Drug Monitoring | 1 | 2012 | 184 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 1996 | 1133 | 0.020 |
Why?
| Carboxyhemoglobin | 1 | 1991 | 5 | 0.020 |
Why?
| Thermodilution | 1 | 1991 | 12 | 0.020 |
Why?
| Radioisotopes | 1 | 1991 | 28 | 0.020 |
Why?
| Ultrasonography | 1 | 2015 | 636 | 0.020 |
Why?
| RNA, Messenger | 3 | 2007 | 2563 | 0.020 |
Why?
| Body Constitution | 1 | 1991 | 47 | 0.020 |
Why?
| Burns | 2 | 1991 | 238 | 0.020 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2003 | 141 | 0.020 |
Why?
| Adolescent | 6 | 2003 | 17864 | 0.020 |
Why?
| Models, Cardiovascular | 1 | 1992 | 179 | 0.020 |
Why?
| Biological Transport | 1 | 1991 | 372 | 0.020 |
Why?
| Echovirus Infections | 1 | 1990 | 1 | 0.020 |
Why?
| Preoperative Period | 1 | 2010 | 103 | 0.020 |
Why?
| Enterovirus B, Human | 1 | 1990 | 24 | 0.020 |
Why?
| Meningoencephalitis | 1 | 1990 | 24 | 0.020 |
Why?
| Blotting, Western | 2 | 2005 | 1149 | 0.020 |
Why?
| Guanidines | 2 | 2001 | 33 | 0.020 |
Why?
| Hospital Costs | 1 | 2010 | 103 | 0.020 |
Why?
| Neurologic Examination | 1 | 2009 | 115 | 0.020 |
Why?
| DNA | 1 | 1996 | 1352 | 0.020 |
Why?
| Pressure | 2 | 2002 | 219 | 0.020 |
Why?
| Macrophages, Alveolar | 1 | 1991 | 351 | 0.020 |
Why?
| Heart Diseases | 1 | 1992 | 330 | 0.020 |
Why?
| Constriction | 2 | 1999 | 45 | 0.020 |
Why?
| Cells, Cultured | 1 | 1996 | 3896 | 0.020 |
Why?
| Immunologic Techniques | 2 | 1999 | 39 | 0.020 |
Why?
| Acute Kidney Injury | 1 | 2014 | 638 | 0.020 |
Why?
| Receptor, Endothelin B | 2 | 2000 | 51 | 0.020 |
Why?
| Regression Analysis | 1 | 2010 | 948 | 0.020 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 1990 | 590 | 0.020 |
Why?
| Heart Rate, Fetal | 2 | 1999 | 20 | 0.020 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2007 | 26 | 0.020 |
Why?
| Stress, Mechanical | 2 | 1999 | 447 | 0.020 |
Why?
| Immediate-Early Proteins | 1 | 2007 | 52 | 0.020 |
Why?
| Developmental Disabilities | 1 | 2009 | 238 | 0.020 |
Why?
| Protein Precursors | 2 | 2000 | 119 | 0.020 |
Why?
| RNA, Viral | 1 | 1990 | 567 | 0.020 |
Why?
| Comorbidity | 1 | 2010 | 1457 | 0.020 |
Why?
| Thoracic Diseases | 1 | 2005 | 13 | 0.020 |
Why?
| Respiratory Muscles | 1 | 2005 | 28 | 0.020 |
Why?
| Oscillometry | 1 | 2005 | 33 | 0.020 |
Why?
| Colorado | 1 | 2015 | 4089 | 0.020 |
Why?
| Manometry | 1 | 2005 | 89 | 0.020 |
Why?
| Hypertrophy | 1 | 2005 | 112 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 86 | 0.020 |
Why?
| Muscular Diseases | 1 | 2005 | 106 | 0.010 |
Why?
| Research Design | 1 | 2010 | 930 | 0.010 |
Why?
| Organ Size | 1 | 2005 | 444 | 0.010 |
Why?
| Drug Combinations | 1 | 2005 | 287 | 0.010 |
Why?
| Kidney | 1 | 1991 | 1186 | 0.010 |
Why?
| Pulse Therapy, Drug | 1 | 2003 | 6 | 0.010 |
Why?
| Administration, Intranasal | 1 | 2003 | 75 | 0.010 |
Why?
| Time | 1 | 2003 | 71 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 2007 | 464 | 0.010 |
Why?
| Pyrroles | 1 | 2004 | 181 | 0.010 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 25 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 928 | 0.010 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2002 | 61 | 0.010 |
Why?
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 40 | 0.010 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2002 | 64 | 0.010 |
Why?
| Nifedipine | 1 | 2002 | 29 | 0.010 |
Why?
| Electrocardiography | 1 | 2005 | 562 | 0.010 |
Why?
| Indoles | 1 | 2004 | 304 | 0.010 |
Why?
| Oligonucleotides | 1 | 2002 | 138 | 0.010 |
Why?
| Aging | 1 | 1991 | 1624 | 0.010 |
Why?
| Calcium Channel Blockers | 1 | 2002 | 115 | 0.010 |
Why?
| Amidines | 1 | 2001 | 16 | 0.010 |
Why?
| Benzylamines | 1 | 2001 | 39 | 0.010 |
Why?
| Calcium Channels | 1 | 2002 | 146 | 0.010 |
Why?
| Ligands | 1 | 2003 | 565 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2005 | 2212 | 0.010 |
Why?
| Physical Stimulation | 1 | 2000 | 78 | 0.010 |
Why?
| Lung Diseases, Interstitial | 1 | 2005 | 515 | 0.010 |
Why?
| Lung Volume Measurements | 1 | 1999 | 45 | 0.010 |
Why?
| Charybdotoxin | 1 | 1999 | 6 | 0.010 |
Why?
| Tetraethylammonium | 1 | 1999 | 15 | 0.010 |
Why?
| Muscle, Smooth | 1 | 2000 | 149 | 0.010 |
Why?
| 4-Aminopyridine | 1 | 1999 | 21 | 0.010 |
Why?
| Quality of Life | 1 | 2009 | 2359 | 0.010 |
Why?
| Atrial Function, Right | 1 | 1998 | 12 | 0.010 |
Why?
| Isothiuronium | 1 | 1998 | 3 | 0.010 |
Why?
| Isoenzymes | 1 | 1999 | 286 | 0.010 |
Why?
| Thiazines | 1 | 1998 | 9 | 0.010 |
Why?
| Long-Term Care | 1 | 1998 | 76 | 0.010 |
Why?
| Masks | 1 | 1998 | 46 | 0.010 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 799 | 0.010 |
Why?
| Gene Expression | 1 | 2003 | 1423 | 0.010 |
Why?
| Catheterization | 1 | 1998 | 159 | 0.010 |
Why?
| Medical Records | 1 | 1998 | 155 | 0.010 |
Why?
| Methylene Blue | 1 | 1996 | 22 | 0.010 |
Why?
| Indomethacin | 1 | 1996 | 75 | 0.010 |
Why?
| Cyclooxygenase Inhibitors | 1 | 1996 | 72 | 0.010 |
Why?
| Adenosine | 1 | 1998 | 204 | 0.010 |
Why?
| Staining and Labeling | 1 | 1996 | 135 | 0.010 |
Why?
| Cardiomegaly | 1 | 1997 | 159 | 0.010 |
Why?
| Carcinoma, Papillary, Follicular | 1 | 1995 | 8 | 0.010 |
Why?
| Purinones | 1 | 1995 | 4 | 0.010 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 1995 | 7 | 0.010 |
Why?
| Receptors, Purinergic P1 | 1 | 1995 | 23 | 0.010 |
Why?
| Multivariate Analysis | 1 | 1999 | 1435 | 0.010 |
Why?
| Adenocarcinoma, Follicular | 1 | 1995 | 34 | 0.010 |
Why?
| Arterioles | 1 | 1995 | 39 | 0.010 |
Why?
| Home Care Services | 1 | 1998 | 222 | 0.010 |
Why?
| Theophylline | 1 | 1995 | 60 | 0.010 |
Why?
| Carcinoma, Papillary | 1 | 1995 | 73 | 0.010 |
Why?
| Neurotransmitter Agents | 1 | 1995 | 77 | 0.010 |
Why?
| Phenylephrine | 1 | 1995 | 74 | 0.010 |
Why?
| Renal Circulation | 1 | 1995 | 53 | 0.010 |
Why?
| Adrenal Glands | 1 | 1995 | 67 | 0.010 |
Why?
| Viper Venoms | 1 | 1994 | 9 | 0.010 |
Why?
| Muscle Tonus | 1 | 1994 | 18 | 0.010 |
Why?
| Neoplasm Invasiveness | 1 | 1995 | 442 | 0.010 |
Why?
| Forecasting | 1 | 1995 | 332 | 0.010 |
Why?
| Perfusion | 1 | 1994 | 151 | 0.010 |
Why?
| Cause of Death | 1 | 1995 | 364 | 0.010 |
Why?
| Intestines | 1 | 1995 | 322 | 0.010 |
Why?
| Extracellular Matrix | 1 | 1995 | 436 | 0.010 |
Why?
| Chemotaxis | 1 | 1991 | 130 | 0.010 |
Why?
| Macrophage Activation | 1 | 1991 | 164 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1990 | 25 | 0.010 |
Why?
| Agammaglobulinemia | 1 | 1990 | 29 | 0.010 |
Why?
| Gene Amplification | 1 | 1990 | 95 | 0.010 |
Why?
| Nucleic Acid Hybridization | 1 | 1990 | 187 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1991 | 1036 | 0.010 |
Why?
| Adenocarcinoma | 1 | 1995 | 795 | 0.010 |
Why?
| Cell Count | 1 | 1990 | 304 | 0.010 |
Why?
| Myocardial Contraction | 1 | 1990 | 313 | 0.000 |
Why?
| Eosinophils | 1 | 1990 | 281 | 0.000 |
Why?
| Polymerase Chain Reaction | 1 | 1990 | 999 | 0.000 |
Why?
| Monocytes | 1 | 1990 | 503 | 0.000 |
Why?
| Skin | 1 | 1990 | 659 | 0.000 |
Why?
| Macrophages | 1 | 1990 | 1267 | 0.000 |
Why?
|
|
Kinsella's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|